This inventor holds 4 USPTO granted patents. Top assignees: Mitsubishi Kasei Corporation, Mitsubishi Chemical Industries Limited. Active years: 1989-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ami, JP (1989)
- Sendai, JP (1990 - 1992)
Company Filing History:

Years Active: 1989-1992
Title: Satoshi Yuki: Innovator in Lipid-Peroxide Formation Inhibition
Introduction
Satoshi Yuki is a prominent inventor based in Sendai, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of lipid-peroxide formation inhibitors. With a total of 4 patents, Yuki's work focuses on therapeutic solutions for ischemic diseases.
Latest Patents
Yuki's latest patents include a lipid-peroxide formation inhibiting composition and novel compounds. This invention serves as a preventive and therapeutic medicine against various ischemic diseases, including brain diseases, heart diseases, and peripheral circulatory diseases. Additionally, he has developed novel pyrazolone derivatives that exhibit similar inhibitory activity and their pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Satoshi Yuki has worked with notable companies such as Mitsubishi Kasei Corporation and Mitsubishi Chemical Industries Limited. His experience in these organizations has allowed him to refine his expertise in the field of medicinal chemistry.
Collaborations
Yuki has collaborated with esteemed colleagues, including Hiroyoshi Nishi and Toshiaki Watanabe. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Satoshi Yuki's contributions to the field of lipid-peroxide formation inhibition highlight his role as a key innovator in medicinal chemistry. His patents and collaborations reflect his commitment to developing effective therapeutic solutions for critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile